Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA drug recalls in 2022

Every FDA drug recall initiated in 2022, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.

1,390 recalls, newest first.

Class I · High risk

Morphine Sulfate extended-Release Tablets

Labeling: Label Mix-up: bottles labeled as Morphine Sulfate 60 mg Extended-Release tablets contain Morphine Sulfate 30 mg Extended-Release tablets and bottles labeled as Morphine Sulfate 30 mg Extended-Release tablets may contain Morphine Sulfate 60 mg Extended-Release tablets.

Terminated Labeling / mix-up Bryant Ranch Prepack, Inc. NDC 63629-1089-01 D-1188-2022
Class I · High risk

Morphine Sulfate extended-Release Tablets

Labeling: Label Mix-up: bottles labeled as Morphine Sulfate 60 mg Extended-Release tablets contain Morphine Sulfate 30 mg Extended-Release tablets and bottles labeled as Morphine Sulfate 30 mg Extended-Release tablets may contain Morphine Sulfate 60 mg Extended-Release tablets.

Terminated Labeling / mix-up Bryant Ranch Prepack, Inc. D-1187-2022
Class II · Moderate risk

Draximage MAA

Lack of Assurance of Sterility: Out-of-specification test results obtained for Endotoxin testing.

Terminated Sterility / contamination Jubilant Draximage Inc NDC 65174-270-30 D-1189-2022

Recalls by year